Clinical Trial Update: MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating MRI to predict tumor response after radiofrequency ablation in women with invasive breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Breast Cancer

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Breast Cancer | Phase 2 | Status: WITHDRAWN